Prostate-specific antigen kinetics after I125-brachytherapy for prostate adenocarcinoma.
about
PSA bounce after ¹²⁵I-brachytherapy for prostate cancer as a favorable prognosticator.May non-metastatic clinically localized castration-resistant prostate cancer after primary androgen ablation benefit from salvage prostate radiotherapy?PSA-nadir at 1 year as a sound contemporary prognostic factor for low-dose-rate iodine-125 seeds brachytherapy.Erectile function status is highly associated with prostate-specific antigen bounce in localized prostate cancer patients treated with permanent prostate brachytherapy.Association between long-term erectile dysfunction and biochemical recurrence after permanent seed I(125) implant brachytherapy for prostate cancer. A longitudinal study of a single-institution.
P2860
Prostate-specific antigen kinetics after I125-brachytherapy for prostate adenocarcinoma.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Prostate-specific antigen kinetics after I125-brachytherapy for prostate adenocarcinoma.
@en
Prostate-specific antigen kinetics after I125-brachytherapy for prostate adenocarcinoma.
@nl
type
label
Prostate-specific antigen kinetics after I125-brachytherapy for prostate adenocarcinoma.
@en
Prostate-specific antigen kinetics after I125-brachytherapy for prostate adenocarcinoma.
@nl
prefLabel
Prostate-specific antigen kinetics after I125-brachytherapy for prostate adenocarcinoma.
@en
Prostate-specific antigen kinetics after I125-brachytherapy for prostate adenocarcinoma.
@nl
P2093
P2860
P50
P1476
Prostate-specific antigen kinetics after I125-brachytherapy for prostate adenocarcinoma.
@en
P2093
Alessandro Tizzani
Alessia Guarneri
Angela Botticella
Fernando Munoz
Giovanni Casetta
P2860
P2888
P304
P356
10.1007/S00345-012-0932-Z
P577
2012-08-26T00:00:00Z